You are here: Home: NHLU 1 2004 : Faculty disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
Sandra J Horning, MD Grant/Research Support: Amgen Inc, Biogen
Idec Inc, Coley Pharmaceutical Group Inc, Corixa
Corporation, Genentech BioOncology, Millennium
Pharmaceuticals Inc
Consultant: Amgen Inc, Biogen Idec Inc,
Chiron Corporation, Corixa Corporation, Genentech
BioOncology, GlaxoSmithKline, NeoRx Corporation,
OSI Pharmaceuticals, Roche Laboratories Inc, Wyeth
Stock Shareholder: CuraGen Corporation,
Gilead Sciences Inc, Millennium Pharmaceuticals
Inc, Pharmacyclics Inc, QLT Inc
Honorarium: Biogen Idec Inc, Genentech
BioOncology, Nippon Roche KK |
John D Hainsworth, MD Grant/Research Support: Biogen Idec Inc,
Genentech BioOncology, Millennium
Pharmaceuticals Inc |

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
|